In this blog post, I aim to summarize common concerns about GMOs and the ongoing debate from a scientific perspective.
What Are GMOs, and Why Does the Debate Continue?
GMOs (Genetically Modified Organisms) refer to crops or organisms that possess traits or genes difficult to obtain through conventional breeding methods, created using genetic recombination technology. They are typically developed to increase yields, enhance pest and disease resistance, and improve convenience in distribution and processing. In many countries around the world, crops such as soybeans, corn, and cotton are cultivated on a large scale. In our daily lives, we commonly encounter cooking oil made from GMO soybeans, as well as starch syrup, beverages, and snacks made from GMO corn.
The debate surrounding GMOs is broadly divided into two camps. Opponents argue that consuming genetically modified foods or releasing them into the environment without sufficient verification is dangerous, as it could lead to long-term and unpredictable harm. Conversely, proponents counter that GMO research and utilization are essential from the perspective of global food issues and food security, and that they can help alleviate hunger and poverty.
What is interesting is that the two camps take different approaches. While opponents primarily emphasize scientific uncertainty and potential risks, proponents largely set aside or accept the scientific safety debate, instead placing ethical and social necessities (e.g., solving food problems) at the forefront. Because of this dynamic, the public often retains a simplistic impression that “GMOs are bad” for a long time.
Scientific Review of Arguments and Current Status of Safety Assurance
Opponents raise two main concerns. First is the potential for ecological disruption and unexpected side effects caused by genetic recombination; second is the possibility that the spread of genes (e.g., through pollination) could lead to irreversible changes. While some cases have indeed caused ecological and health problems, generalizing that all GMOs pose a high risk based solely on these examples risks falling into the trap of inductive fallacy. In particular, extreme cases of interspecies hybridization may differ in nature from commercially available GMOs.
A common concern cited involves experiments that combine genes from different species to create new traits; however, there is a counterargument that the likelihood of such experiments being commercialized as-is is low. In reality, while genetic recombination technology is often misunderstood as allowing “anything to be combined,” technical constraints and safety verification processes make it difficult for arbitrary combinations to reach the market.
The process of developing and commercializing GMOs involves a relatively long timeframe and rigorous verification. It typically takes more than 10 years of research, testing, and evaluation before a GMO crop reaches the market, during which numerous repeated experiments and safety assessments are conducted. These procedures are sometimes considered to be as strict as clinical trials for pharmaceuticals. Claims of harmfulness raised in some papers or news reports have, in some cases, been deemed scientifically flawed in subsequent reviews.
Meanwhile, researchers are simultaneously conducting studies to reduce risks during the GMO development process. Technological advancements have always been accompanied by potential side effects, and as the cases of antibiotics and fossil fuels demonstrate, the development of science and technology can generate both positive effects and side effects simultaneously. Therefore, it is argued that rather than completely halting technological development solely on the basis of potential risks, research should proceed in a direction that minimizes negative impacts.
Current safety assessments are strictly conducted, divided into human health risks and environmental risks. Human safety assessments include evaluations of toxicity, the stability of inserted genes, potential to cause allergies, nutritional changes, and the occurrence of unintended effects. Environmental safety assessments examine the persistence of GMO genes, impacts on non-target organisms, the potential for the early emergence of resistant insects, and the potential for new plant pathogens to emerge. Only when these criteria are met is the product permitted to be marketed as food.
Nevertheless, additional measures are needed to reduce any remaining risks. Prior to market introduction, rigorous testing and verification must ensure that development can be immediately halted or discontinued if any adverse effects are detected. Even after market release, it is crucial to establish a traceability system to enable rapid detection and response should any GMO-related impacts arise.
In conclusion, GMO development does not inherently pose risks that warrant an unconditional halt, and significant safety safeguards are currently in place. At the same time, technological progress cannot be halted in the name of perfection; therefore, it is desirable to continue research and development within safe parameters to address practical challenges such as food security, while simultaneously implementing realistic risk management. It is a social obligation for scientists and policymakers to take responsibility for strengthening these safety measures.
